AGP Picks
View all

The most trusted news from Latin America

Provided by AGP

Good Morning! Latin America: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Good Morning! Latin America.

Press releases published on April 30, 2026

Resource Outlined on Globex’s Eagle Gold Mine Property
WEALTH UNTOLD Expands International Tour Across Europe and Oceania
Dynacor Group Announces May 2026 Dividend
Groupe Dynacor déclare son dividende pour mai 2026
FEMSA Announces First Quarter 2026 Results
FEMSA Anuncia Resultados del Primer Trimestre 2026
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
VIVUS ogłasza obniżkę ceny produktu QSIVA® w krajach nordyckich i w Polsce
A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine
Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting
Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
Banco Itaú Chile Announces First Quarter 2026 Management Commentary
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange
Oncotelic Therapeutics Advances Toward Commercial Launch of AI-Enabled Robotics Platform Following Integration of 28 Million Scientific Abstracts
GoldHaven Announces C$5.0M LIFE Offering to Advance Magno and Copeçal Projects
Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026
Critical Metals Corp. Closes Acquisition of Final 50.5% Interest in Tanbreez, Bringing Current Ownership to 92.5%
NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026
The KCNT1 Epilepsy Foundation and NORD® Launch Global KCNT1 Registry

Share us

on your social networks:

Sign up for:

Good Morning! Latin America

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.